Sarcoma  >>  pegylated liposomal doxorubicin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pegylated liposomal doxorubicin / Generic mfg.
NCT00346125: PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma

Completed
N/A
70
US
pegfilgrastim, Neulasta(R), doxorubicin hydrochloride, Doxorubicin, Adriamycin, ifosfamide, Mitoxana, Ifex, pegylated liposomal doxorubicin hydrochloride, doxorubicin-hydrochloride-liposome, conventional surgery, fludeoxyglucose F 18, FDG
Masonic Cancer Center, University of Minnesota
Sarcoma
07/13
07/22
NCT04055753: Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Active, not recruiting
N/A
24
US
Doxil, Doxorubicin
Fox Chase Cancer Center
Soft Tissue Sarcoma
06/21
05/24

Download Options